11 pending office actions • 5 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Sanofi | 4 |
| Translate Bio, Inc. | 4 |
| Kadmon Corporation, LLC | 1 |
| Translate Bio, Inc. | 1 |
| SK Bioscience Co., Ltd. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18631600 | NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | Sanofi | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Apr 10, 2024 |
| 18434994 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase | Kadmon Corporation, LLC | MCDOWELL, BRIAN E | 1624 | Final Rejection | Feb 07, 2024 |
| 18578547 | 6H-IMIDAZO[1,2-A]PYRROLO[2,3-E]PYRIDINE DERIVATIVES FOR USE IN THERAPY | Sanofi | MCANANY, JOHN D | 1625 | Non-Final OA | Jan 11, 2024 |
| 18575019 | COMPOSITIONS FOR DELIVERY OF MRNA | Translate Bio, Inc. | RONEY, CELESTE A | 1612 | Non-Final OA | Dec 28, 2023 |
| 17917375 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFOX | Sanofi | SKOKO III, JOHN JOSEPH | 1643 | Non-Final OA | Oct 06, 2022 |
| 17916737 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES, TRIFLURIDINE AND TIPIRACIL | Sanofi | DUFFY, BRADLEY | 1643 | Non-Final OA | Oct 03, 2022 |
| 17630841 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITIONS AND METHODS OF USING THE SAME | SK Bioscience Co., Ltd. | SHAHNAN SHAH, KHATOL S | 1645 | Non-Final OA | Jan 27, 2022 |
| 17534956 | Stable Liquid Lipid Nanoparticle Formulations | Translate Bio, Inc. | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Nov 24, 2021 |
| 17611020 | IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | Translate Bio, Inc. | MITCHELL, EDWIN COLEMAN | 1619 | Non-Final OA | Nov 12, 2021 |
| 17292923 | METHODS FOR INDUCING IMMUNE TOLERANCE | Translate Bio, Inc. | BURKHART, MICHAEL D | 1638 | Non-Final OA | May 11, 2021 |
| 17055251 | Subcutaneous Delivery of Messenger RNA | Translate Bio, Inc. | ARIETI, RUTH SOPHIA | 1635 | Final Rejection | Nov 13, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial